Info: Read More
  • 中药标准品生产商,产品定制服务
  • 梓苷

    Catalposide

    梓苷
    产品编号 CFN97148
    CAS编号 6736-85-2
    分子式 = 分子量 C22H26O12 = 482.4
    产品纯度 >=98%
    物理属性 Powder
    化合物类型 Iridoids
    植物来源 The herbs of Catalpa ovata G.Don
    ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用
    提供自定义包装
    产品名称 产品编号 CAS编号 包装 QQ客服
    梓苷 CFN97148 6736-85-2 1mg QQ客服:3257982914
    梓苷 CFN97148 6736-85-2 5mg QQ客服:3257982914
    梓苷 CFN97148 6736-85-2 10mg QQ客服:3257982914
    梓苷 CFN97148 6736-85-2 20mg QQ客服:3257982914
    存储与注意事项
    1. 在您收到产品后请检查产品。如无问题,请将产品存入冰霜并且样品瓶保持密封,产品可以存放长达24个月(2-8摄氏度)。

    2. 只要有可能,产品溶解后,您应该在同一天应用于您的实验。 但是,如果您需要提前做预实验,或者需要全部溶解,我们建议您将溶液以等分试样的形式存放在-20℃的密封小瓶中。 通常,这些可用于长达两周。 使用前,打开样品瓶前,我们建议您将产品平衡至室温至少1小时。

    3. 需要更多关于溶解度,使用和处理的建议? 请发送电子邮件至:service@chemfaces.com
    订购流程
  • 1. 在线订购
  • 请联系我们QQ客服

  • 2. 电话订购
  • 请拨打电话:
    027-84237683 或 027-84237783

  • 3. 邮件或传真订购
  • 发送电子邮件到: manager@chemfaces.com 或
    发送传真到:027-84254680

  • 提供订购信息
  • 为了方便客户的订购,请需要订购ChemFaces产品的客户,在下单的时候请提供下列信息,以供我们快速为您建立发货信息。
  •  
  • 1. 产品编号(CAS No.或产品名称)
  • 2. 发货地址
  • 3. 联系方法 (联系人,电话)
  • 4. 开票抬头 (如果需要发票的客户)
  • 5. 发票地址(发货地址与发票地址不同)
  • 发货时间
    1. 付款方式为100%预付款客户,我们将在确认收到货款后当天或1-3个工作日发货。

    2. 付款方式为月结的客户,我们承诺在收到订单后当天或1-3个工作日内发货。

    3. 如果客户所需要的产品,需要重新生产,我们有权告知客户,交货时间需要延期。
    ChemFaces的产品在许多优秀和顶级科学期刊中被引用

    Cell. 2018 Jan 11;172(1-2):249-261.e12.
    doi: 10.1016/j.cell.2017.12.019.
    IF=36.216(2019)

    PMID: 29328914

    Cell Metab. 2020 Mar 3;31(3):534-548.e5.
    doi: 10.1016/j.cmet.2020.01.002.
    IF=22.415(2019)

    PMID: 32004475

    Mol Cell. 2017 Nov 16;68(4):673-685.e6.
    doi: 10.1016/j.molcel.2017.10.022.
    IF=14.548(2019)

    PMID: 29149595

    ACS Nano. 2018 Apr 24;12(4): 3385-3396.
    doi: 10.1021/acsnano.7b08969.
    IF=13.903(2019)

    PMID: 29553709

    Nature Plants. 2016 Dec 22;3: 16206.
    doi: 10.1038/nplants.2016.205.
    IF=13.297(2019)

    PMID: 28005066

    Sci Adv. 2018 Oct 24;4(10): eaat6994.
    doi: 10.1126/sciadv.aat6994.
    IF=12.804(2019)

    PMID: 30417089
    我们的产品现已经出口到下面的研究机构与大学,并且还在增涨
  • University of the Basque Country (Spain)
  • Imperial College London (United Kingdom)
  • Instytut Nawozów Sztucznych w Pu?awach (Poland)
  • National Hellenic Research Foundation (Greece)
  • Funda??o Universitária de Desenvolvimento (Brazil)
  • Instituto Politécnico de Bragan?a (Portugal)
  • The Australian National University (Australia)
  • Molecular Biology Institute of Barcelona (IBMB)-CSIC (Spain)
  • Weizmann Institute of Science (Israel)
  • Florida A&M University (USA)
  • Monash University Sunway Campus (Malaysia)
  • Cornell University (USA)
  • Medical University of South Carolina (USA)
  • Heidelberg University (Germany)
  • More...
  • 国外学术期刊发表的引用ChemFaces产品的部分文献
  • Molecules.2020, 25(21):5087.
  • Molecules.2019, 24(4):E744
  • Nat Chem Biol.2018, 14(8):760-763
  • Cardiovasc Toxicol.2019, 19(4):297-305
  • Research Square2021, March 3rd.
  • Research Square2021, 10.21203.
  • LWT2021, 147:111620.
  • Molecules.2019, 24(12):E2286
  • Agriculture.2022, 12(3), 342.
  • Clin Transl Med.2021, 11(5):e392.
  • Drug Invention Today2019, 12(6):1303-1306
  • Sci Rep.2023, 13(1):14594.
  • Front Pharmacol.2021, 12:635510.
  • Universite de Bordeaux2017, 2017BORD0867
  • J. Pharm. Res. Int.2022, 34(58): pp.1-14.
  • Nutrients.2018, 10(12)
  • J Ethnopharmacol.2019, 236:31-41
  • Biochem Biophys Res Commun.2018, 505(1):261-266
  • Microbiol. Biotechnol. Lett.2022, 50(2): 193-201.
  • J Enzyme Inhib Med Chem.2019, 34(1):134-143
  • Bioorg Med Chem.2020, 28(12):115553.
  • Sci Rep. 2018, 10590
  • Anal Bioanal Chem.2016, 408(1):177-90.
  • ...
  • 生物活性
    Description: Catalposide possesses antioxidant, anti-apoptotic, anti-microbial, anti-tumoral, and anti-inflammatory properties. Catalposide is a potent inducer of HO-1 and HO-1 induction is responsible for the catalposide-mediated cytoprotection against oxidative damage.Catalposide is a natural agonistic ligand of peroxisome proliferator-activated receptor-α, is hypolipidemic by activation of PPARαvia a ligand-mediated mechanism that modulates the expression of in lipid metabolism genes in hepatocytes.
    Targets: PPAR | NO | NOS | HO-1 | NF-kB | p65 | TNF-α | IL Receptor | ERK
    In vitro:
    J Pharm Biomed Anal. 2008 Sep 10;48(1):127-33.
    Electrochemical and spectrometric study of antioxidant activity of pomiferin, isopomiferin, osajin and catalposide.[Pubmed: 18597965]
    The antioxidant properties of pomiferin, isopomiferin, osajin and Catalposide are evaluated. The electrochemical behaviour of these compounds at a carbon paste electrode was studied using square wave voltammetry.
    METHODS AND RESULTS:
    Oxidative signals, optimized frequencies and appropriate pH acetate buffer conditions were determined. The detection limits (3S/N) for pomiferin, isopomiferin, osajin and Catalposide were estimated to be 50 pg/ml, 800 pg/ml, 40 pg/ml and 10 ng/ml, respectively. Furthermore, spectrometric test was employed with 2,2-diphenyl-1-picrylhydrazyle (DPPH) to evaluate the antioxidant activities of these compounds. Based on the obtained results, the highest antioxidant activity measured by DPPH tests was found at pomiferin followed by isopomiferin. The activities of osajin and Catalposide were undetectable. The protective effects of pomiferin, isopomiferin, osajin and Catalposide on DNA exposed to oxygen radicals in vitro were also studied. Changes in height of oxidative signals for the four bases (guanine, thymine, adenine and cytosine) were measured for DNA exposed to oxygen radicals, generated by Fenton's reaction, non-oxidized ssDNA (50 microg/ml) displayed well developed signals; however, after oxidative damage the observed oxidative signals decreased. Significant protective effects were observed for pomiferin and osajin. Decreased effect was observed for isopomiferin while a further reduced protective effect was seen for DNA exposed to Catalposide.
    CONCLUSIONS:
    Based on the obtained results, pomiferin had the highest antioxidant activity followed by isopomiferin, osajin and Catalposide.
    Planta Med. 2002 Aug;68(8):685-9.
    Inhibition of inducible nitric oxide synthesis by catalposide from Catalpa ovata.[Pubmed: 12221588]
    Catalposide (1) and two related iridoids were isolated from the stem of Catalpa ovata (Bignoniaceae) by bioassay guided fractionation.
    METHODS AND RESULTS:
    Catalposide (1) significantly inhibited the production of nitric oxide (NO) in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages in a dose-dependent manner. RT-PCR and Western blot analyses demonstrated that Catalposide (1) suppressed the expression of inducible nitric oxide synthase (iNOS) gene and iNOS protein. Catalposide (1) also inhibited the activation of LPS-induced NF-kappaB as analyzed by electrophoretic mobility shift assay (EMSA). In addition to the inhibitory effect on NO production in LPS-stimulated RAW 264.7 cells, Catalposide (1) significantly inhibited the NO production in cytokine-stimulated human DLD-1 and rat vascular smooth muscle (VSM) cells in a dose-dependent manner.
    Int Immunopharmacol. 2002 Jul;2(8):1173-81.
    Inhibition of TNF-alpha, IL-1beta, and IL-6 productions and NF-kappa B activation in lipopolysaccharide-activated RAW 264.7 macrophages by catalposide, an iridoid glycoside isolated from Catalpa ovata G. Don (Bignoniaceae).[Pubmed: 12349954]

    METHODS AND RESULTS:
    Catalposide, the major iridoid glycoside isolated from the stem bark of Catalpa ovata G. Don (Bignoniaceae), was found to inhibit the productions of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and interleukin-6 (IL-6), and the activation of nuclear factor kappaB (NF-kappaB) in RAW 264.7 macrophages activated with lipopolysaccharide (LPS). Catalposide also inhibited the expressions of TNF-alpha, IL-1beta, and IL-6 genes and the nuclear translocation of p65 subunit of NF-kappaB in LPS-activated RAW 264.7 cells. Flow cytometric analysis revealed that Catalposide suppressed the binding of FITC-conjugated LPS to CD14 on the surface of cells, probably resulting in the inhibitory effects on TNF-alpha, IL-1beta, and IL-6 productions and NF-kappaB activation.
    CONCLUSIONS:
    These findings suggest that Catalposide could be an attractive candidate for adjunctive therapy in gram-negative bacterial infections.
    制备储备液(仅供参考)
    1 mg 5 mg 10 mg 20 mg 25 mg
    1 mM 2.073 mL 10.3648 mL 20.7297 mL 41.4594 mL 51.8242 mL
    5 mM 0.4146 mL 2.073 mL 4.1459 mL 8.2919 mL 10.3648 mL
    10 mM 0.2073 mL 1.0365 mL 2.073 mL 4.1459 mL 5.1824 mL
    50 mM 0.0415 mL 0.2073 mL 0.4146 mL 0.8292 mL 1.0365 mL
    100 mM 0.0207 mL 0.1036 mL 0.2073 mL 0.4146 mL 0.5182 mL
    * Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
    部分图片展示
    产品名称 产品编号 CAS编号 分子式 = 分子量 位单 联系QQ
    梓醇; Catalpol CFN98251 2415-24-9 C15H22O10 = 362.3 20mg QQ客服:2056216494
    地黄苷A; Rehmannioside A CFN90761 81720-05-0 C21H32O15 = 524.5 5mg QQ客服:1457312923
    6-O-甲基梓醇; 6-O-Methylcatalpol CFN91711 1617-84-1 C16H24O10 = 376.4 5mg QQ客服:1413575084
    梓苷; Catalposide CFN97148 6736-85-2 C22H26O12 = 482.4 10mg QQ客服:2159513211
    6'-O-对羟基苯甲酰基梓甙; 6'-O-p-Hydroxybenzoylcatalposide CFN98471 355143-38-3 C29H30O14 = 602.6 5mg QQ客服:1457312923
    胡黄连苷II; Picroside II CFN99566 39012-20-9 C23H28O13 = 512.47 20mg QQ客服:2159513211
    球花苦苷; Globularin CFN99451 1399-49-1 C24H28O11 = 492.5 5mg QQ客服:1457312923
    10-O-trans-对甲氧基肉桂酰梓醇; 10-O-trans-p-methoxycinnamoyl-catalpol CFN91677 201605-27-8 C25H30O12 = 522.5 5mg QQ客服:1413575084
    10-O-[(E)-3,4-二甲氧基肉桂酰)梓醇; 10-O-[(E)-3,4-Dimethoxycinnamoyl]-catalpol CFN91676 834155-36-1 C26H32O13 = 552.5 5mg QQ客服:2056216494
    Procumbide; Procumbide CFN96021 20486-27-5 C15H22O10 = 362.3 5mg QQ客服:3257982914

    信息支持


    公司简介
    订购流程
    付款方式
    退换货政策

    ChemFaces提供的产品仅用于科学研究使用,不用于诊断或治疗程序。

    联系方式


    电机:027-84237783
    传真:027-84254680
    在线QQ: 1413575084
    E-Mail:manager@chemfaces.com

    湖北省武汉沌口经济技术开区车城南路83号1号楼第三层厂房


    ChemFaces为科学家,科研人员与企业提供快速的产品递送。我们通过瑞士SGS ISO 9001:2008质量体系认证天然化合物与对照品的研发和生产